Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-28

Clinical Trial Update: Effect of MTX Discontinuation on Shingrix Response in RA [NA]

View source ↗

Summary

A recruiting study evaluating whether discontinuing methotrexate affects the immune response to Shingrix in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Konkuk University Medical Center | Conditions: Rheumatoid Arthritis | NA | Status: RECRUITING